Literature DB >> 17176981

2-Deoxy-2-[F-18]fluoro-D-glucose positron emission tomography illustrates two visceral tumors in a post kidney transplant patient with multiple cutaneous malignancies.

Wei-Jen Shih1, Bonnie Mitchell, Primo Milan, Wen-Sheng Huang.   

Abstract

The success of renal transplantation brings with it the dilemma of managing patients with complications from lifelong immunosuppressive therapy. Immunosuppressed transplant recipients are a special population with significantly increased risk for development of skin cancers. Because malignant tumors are increasing as demonstrated on 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) positron emission tomography (PET) image, we report the unusual coincidence of multiple cutaneous cancers and two visceral malignancies 20 years after renal transplantation. The malignancies include basal cell and squamous cell carcinomas and malignant fibrous histiocytoma. FDG-PET images show, in this case, visceral masses with increased metabolism: one in the left upper lung and one in the abdomen, corresponding to individual mass lesions observed on computed tomography (CT) images of the chest and abdomen. A fine-needle biopsy of the nodule of the left upper lung lobe yielded a diagnosis of a sarcoma. The mass lesion of the abdomen had caused bowel obstruction, requiring exploratory laparotomy; histopathological findings from the resected mass from the abdomen confirmed the diagnosis malignant fibrous histiocytoma. This long-term immune suppressed transplant recipient developed viscerally located malignant lesions demonstrated by FDG-PET imaging and three types of cutaneous malignancies (skin cancers).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17176981     DOI: 10.1007/s11307-006-0070-3

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  16 in total

Review 1.  Skin cancers after organ transplantation.

Authors:  Sylvie Euvrard; Jean Kanitakis; Alain Claudy
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

Review 2.  Skin cancers after transplantation.

Authors:  Brigitte Dreno
Journal:  Nephrol Dial Transplant       Date:  2003-06       Impact factor: 5.992

3.  Kaposi's sarcoma in recipients of renal transplants.

Authors:  A R Harwood; D Osoba; S L Hofstader; M B Goldstein; C J Cardella; M J Holecek; R Kunynetz; R A Giammarco
Journal:  Am J Med       Date:  1979-11       Impact factor: 4.965

Review 4.  Kaposi's sarcoma in transplant recipients.

Authors:  I Penn
Journal:  Transplantation       Date:  1997-09-15       Impact factor: 4.939

5.  Kaposi's sarcoma in organ transplant recipients. The Collaborative Transplantation Research Group of Ile de France.

Authors:  D Farge
Journal:  Eur J Med       Date:  1993 Jun-Jul

6.  Kaposi's sarcoma: a byproduct of tumour rejection.

Authors:  T F Warner; S O'Loughlin
Journal:  Lancet       Date:  1975-10-11       Impact factor: 79.321

7.  Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors.

Authors:  Patrizia Barozzi; Mario Luppi; Fabio Facchetti; Cristina Mecucci; Milena Alù; Ronit Sarid; Valeria Rasini; Luisa Ravazzini; Elisa Rossi; Silvana Festa; Barbara Crescenzi; Dana G Wolf; Thomas F Schulz; Giuseppe Torelli
Journal:  Nat Med       Date:  2003-04-07       Impact factor: 53.440

Review 8.  Sarcomas in organ allograft recipients.

Authors:  I Penn
Journal:  Transplantation       Date:  1995-12-27       Impact factor: 4.939

Review 9.  Squamous cell carcinoma in solid-organ transplantation.

Authors:  Jashin J Wu; Ida F Orengo
Journal:  Dermatol Online J       Date:  2002-10

10.  Dermatofibrosarcoma protuberans in a renal transplant patient.

Authors:  K N Lai; F M Lai; W W King; P K Li; D Siu; C B Leung; S F Lui
Journal:  Aust N Z J Surg       Date:  1995-12
View more
  1 in total

Review 1.  Sarcomas other than Kaposi sarcoma occurring in immunodeficiency: interpretations from a systematic literature review.

Authors:  Kishor Bhatia; Meredith S Shiels; Alexandra Berg; Eric A Engels
Journal:  Curr Opin Oncol       Date:  2012-09       Impact factor: 3.915

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.